Cargando…

Comparative study on the immunopotentiator effect of ISA 201, ISA 61, ISA 50, ISA 206 used in trivalent foot and mouth disease vaccine

AIM: A comparison study was conducted to explore the best internationally available adjuvant that could be used in production of a highly potent foot and mouth disease (FMD) vaccine, that could stimulate a strong immune response and possibly give greater protection against FMD. MATERIALS AND METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Ibrahim, Ehab El-Sayed, Gamal, Wael Mossad, Hassan, Amr Ismail, Mahdy, Safy El-Din, Hegazy, Akram Zakria, Abdel-Atty, Magdy Mahmoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Veterinary World 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4774654/
https://www.ncbi.nlm.nih.gov/pubmed/27047016
http://dx.doi.org/10.14202/vetworld.2015.1189-1198
_version_ 1782418932525694976
author Ibrahim, Ehab El-Sayed
Gamal, Wael Mossad
Hassan, Amr Ismail
Mahdy, Safy El-Din
Hegazy, Akram Zakria
Abdel-Atty, Magdy Mahmoud
author_facet Ibrahim, Ehab El-Sayed
Gamal, Wael Mossad
Hassan, Amr Ismail
Mahdy, Safy El-Din
Hegazy, Akram Zakria
Abdel-Atty, Magdy Mahmoud
author_sort Ibrahim, Ehab El-Sayed
collection PubMed
description AIM: A comparison study was conducted to explore the best internationally available adjuvant that could be used in production of a highly potent foot and mouth disease (FMD) vaccine, that could stimulate a strong immune response and possibly give greater protection against FMD. MATERIALS AND METHODS: Four experimental batches of trivalent FMD vaccine were prepared with different available oil adjuvants which included Montanide ISA 201, 206, 61 and 50. RESULTS: The results indicated that vaccines emulsified using Montanide ISA 201 and Montanide ISA 206 adjuvants elicited a protective humoral immune response from the 2(nd) week postvaccination (WPV) as for ISA 201 with serum neutralization test (SNT) and enzyme-linked immune sorbent assay (ELISA) antibody titers of 1.62±0.047(a) and 1.8±0.049(a), 1.59±0.076(a) and 1.836±0.077(a), and 1.71±0.06(b) and 1.96±0.074(b) for serotypes O, A, SAT2, respectively, and for ISA 206 at SNT and ELISA antibody titers of 1.5±0.082(a) and 1.84±0.084(a), 1.56±0.037(a) and 1.818±0.052(a), and 1.5±0.106(a,b) and 1.81±0.104(a,b) for FMD virus serotypes O, A and SAT2, respectively. For ISA 61 and ISA 50, the protective antibody titer appeared in the 3(rd) WPV. In the ISA 61 FMD vaccine, SNT and ELISA titer were 1.59±0.076(a) and 1.9±0.094(a), 1.53±0.056(a) and 1.83±0.070(a), and 1.5±0.082(a) and 1.84±0.094(a) for serotypes O, A and SAT2, respectively, and in the case of ISA 50 FMD vaccine, the SNT, and ELISA titer were recorded for serotypes O, A and SAT2 respectively, 1.59±0.037(a) and 1.8±0.030(a), 1.68±0.056(a,b) and 1.916±0.065(a,b), and 1.65±0.082(a) and 1.9±0.09(a). On estimating the cellular immune response, the highest delta optical density levels for ISA 201 (0.395-0.460) and ISA 206 (0.375-0.428) were observed on 14 and 21 days post vaccination (DPV) respectively, while the highest levels of lymphoproliferation for ISA 61 (0.375-0.455) and ISA 50 (0.411-0.430) were on 21 and 28 DPV, respectively. CONCLUSION: The duration of immunity from Montanide ISA oils (201, 206, 61 and 50) FMD vaccines is a long-lived immunity which ranged between 32 and 38 weeks post vaccination but the Montanide ISA 201 FMD vaccine is superior to the others in the rapid cellular immune response of the vaccinated animals which showed its highest level within 14 days post vaccination.
format Online
Article
Text
id pubmed-4774654
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Veterinary World
record_format MEDLINE/PubMed
spelling pubmed-47746542016-04-04 Comparative study on the immunopotentiator effect of ISA 201, ISA 61, ISA 50, ISA 206 used in trivalent foot and mouth disease vaccine Ibrahim, Ehab El-Sayed Gamal, Wael Mossad Hassan, Amr Ismail Mahdy, Safy El-Din Hegazy, Akram Zakria Abdel-Atty, Magdy Mahmoud Vet World Research Article AIM: A comparison study was conducted to explore the best internationally available adjuvant that could be used in production of a highly potent foot and mouth disease (FMD) vaccine, that could stimulate a strong immune response and possibly give greater protection against FMD. MATERIALS AND METHODS: Four experimental batches of trivalent FMD vaccine were prepared with different available oil adjuvants which included Montanide ISA 201, 206, 61 and 50. RESULTS: The results indicated that vaccines emulsified using Montanide ISA 201 and Montanide ISA 206 adjuvants elicited a protective humoral immune response from the 2(nd) week postvaccination (WPV) as for ISA 201 with serum neutralization test (SNT) and enzyme-linked immune sorbent assay (ELISA) antibody titers of 1.62±0.047(a) and 1.8±0.049(a), 1.59±0.076(a) and 1.836±0.077(a), and 1.71±0.06(b) and 1.96±0.074(b) for serotypes O, A, SAT2, respectively, and for ISA 206 at SNT and ELISA antibody titers of 1.5±0.082(a) and 1.84±0.084(a), 1.56±0.037(a) and 1.818±0.052(a), and 1.5±0.106(a,b) and 1.81±0.104(a,b) for FMD virus serotypes O, A and SAT2, respectively. For ISA 61 and ISA 50, the protective antibody titer appeared in the 3(rd) WPV. In the ISA 61 FMD vaccine, SNT and ELISA titer were 1.59±0.076(a) and 1.9±0.094(a), 1.53±0.056(a) and 1.83±0.070(a), and 1.5±0.082(a) and 1.84±0.094(a) for serotypes O, A and SAT2, respectively, and in the case of ISA 50 FMD vaccine, the SNT, and ELISA titer were recorded for serotypes O, A and SAT2 respectively, 1.59±0.037(a) and 1.8±0.030(a), 1.68±0.056(a,b) and 1.916±0.065(a,b), and 1.65±0.082(a) and 1.9±0.09(a). On estimating the cellular immune response, the highest delta optical density levels for ISA 201 (0.395-0.460) and ISA 206 (0.375-0.428) were observed on 14 and 21 days post vaccination (DPV) respectively, while the highest levels of lymphoproliferation for ISA 61 (0.375-0.455) and ISA 50 (0.411-0.430) were on 21 and 28 DPV, respectively. CONCLUSION: The duration of immunity from Montanide ISA oils (201, 206, 61 and 50) FMD vaccines is a long-lived immunity which ranged between 32 and 38 weeks post vaccination but the Montanide ISA 201 FMD vaccine is superior to the others in the rapid cellular immune response of the vaccinated animals which showed its highest level within 14 days post vaccination. Veterinary World 2015-10 2015-10-15 /pmc/articles/PMC4774654/ /pubmed/27047016 http://dx.doi.org/10.14202/vetworld.2015.1189-1198 Text en Copyright: The authors. http://creativecommons.org/licenses/by/2.0 This article is an open access article licensed under the terms of the Creative Commons Attributin License (http://creative commons.org/licenses/by/2.0) which permits unrestricted use, distribution and reproduction in any medium, provided the work is properly cited.
spellingShingle Research Article
Ibrahim, Ehab El-Sayed
Gamal, Wael Mossad
Hassan, Amr Ismail
Mahdy, Safy El-Din
Hegazy, Akram Zakria
Abdel-Atty, Magdy Mahmoud
Comparative study on the immunopotentiator effect of ISA 201, ISA 61, ISA 50, ISA 206 used in trivalent foot and mouth disease vaccine
title Comparative study on the immunopotentiator effect of ISA 201, ISA 61, ISA 50, ISA 206 used in trivalent foot and mouth disease vaccine
title_full Comparative study on the immunopotentiator effect of ISA 201, ISA 61, ISA 50, ISA 206 used in trivalent foot and mouth disease vaccine
title_fullStr Comparative study on the immunopotentiator effect of ISA 201, ISA 61, ISA 50, ISA 206 used in trivalent foot and mouth disease vaccine
title_full_unstemmed Comparative study on the immunopotentiator effect of ISA 201, ISA 61, ISA 50, ISA 206 used in trivalent foot and mouth disease vaccine
title_short Comparative study on the immunopotentiator effect of ISA 201, ISA 61, ISA 50, ISA 206 used in trivalent foot and mouth disease vaccine
title_sort comparative study on the immunopotentiator effect of isa 201, isa 61, isa 50, isa 206 used in trivalent foot and mouth disease vaccine
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4774654/
https://www.ncbi.nlm.nih.gov/pubmed/27047016
http://dx.doi.org/10.14202/vetworld.2015.1189-1198
work_keys_str_mv AT ibrahimehabelsayed comparativestudyontheimmunopotentiatoreffectofisa201isa61isa50isa206usedintrivalentfootandmouthdiseasevaccine
AT gamalwaelmossad comparativestudyontheimmunopotentiatoreffectofisa201isa61isa50isa206usedintrivalentfootandmouthdiseasevaccine
AT hassanamrismail comparativestudyontheimmunopotentiatoreffectofisa201isa61isa50isa206usedintrivalentfootandmouthdiseasevaccine
AT mahdysafyeldin comparativestudyontheimmunopotentiatoreffectofisa201isa61isa50isa206usedintrivalentfootandmouthdiseasevaccine
AT hegazyakramzakria comparativestudyontheimmunopotentiatoreffectofisa201isa61isa50isa206usedintrivalentfootandmouthdiseasevaccine
AT abdelattymagdymahmoud comparativestudyontheimmunopotentiatoreffectofisa201isa61isa50isa206usedintrivalentfootandmouthdiseasevaccine